Profile data is unavailable for this security.
About the company
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
- Revenue in EUR (TTM)246.09m
- Net income in EUR30.01m
- Incorporated1997
- Employees1.08k
- LocationEckert & Ziegler SERobert-Roessle-Str.10BERLIN 13125GermanyDEU
- Phone+49 309410840
- Fax+49 30 941084112
- Websitehttps://www.ezag.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PharmaSGP Holding SE | 97.55m | 14.99m | 259.20m | 85.00 | 17.30 | 7.08 | 10.64 | 2.66 | 1.25 | 1.25 | 8.13 | 3.05 | 0.7592 | 1.15 | 9.69 | 1,234,848.00 | 11.67 | 14.62 | 13.98 | 21.22 | 90.61 | 89.90 | 15.37 | 19.17 | 2.15 | 9.03 | 0.6809 | -- | 31.34 | 10.09 | 11.82 | 0.2886 | 14.67 | -- |
| Formycon AG | 68.64m | -42.24m | 709.81m | 224.00 | -- | 1.51 | -- | 10.34 | -2.80 | -2.80 | 4.41 | 26.65 | 0.079 | 91.54 | 2.24 | 334,839.00 | -4.86 | 3.03 | -5.17 | 3.29 | 35.52 | 31.61 | -61.53 | 10.91 | 1.00 | -- | 0.0202 | 0.00 | 16.07 | 7.86 | 370.82 | -- | 120.72 | -- |
| Eckert & Ziegler SE | 246.09m | 30.01m | 713.07m | 1.08k | 23.39 | 3.16 | 16.26 | 2.90 | 1.44 | 1.26 | 11.81 | 10.67 | 0.5812 | 3.28 | 5.63 | 228,923.70 | 7.20 | 8.50 | 8.67 | 10.23 | 47.29 | 48.61 | 12.39 | 14.00 | 2.31 | 12.77 | 0.2008 | 35.09 | 10.74 | 7.84 | -2.84 | 13.22 | 33.82 | -30.12 |
| Biotest AG | 684.60m | 127.00m | 1.39bn | 2.43k | 12.96 | 3.30 | -- | 2.04 | 3.21 | 3.21 | 17.30 | 12.61 | 0.5238 | 1.13 | 3.84 | 282,192.90 | 9.72 | -0.0693 | 12.10 | -0.079 | 40.94 | 28.43 | 18.55 | -0.1527 | 0.8757 | 3.86 | 0.5803 | -- | 32.65 | 11.33 | 490.89 | -- | -9.36 | -- |
| Dermapharm Holding SE | 1.14bn | 62.37m | 1.72bn | 3.50k | 27.55 | 3.19 | 10.41 | 1.52 | 1.16 | 1.16 | 21.09 | 10.01 | 0.6354 | 1.44 | 12.10 | 324,664.30 | 3.39 | 8.68 | 4.10 | 10.06 | 63.34 | 61.94 | 5.33 | 12.31 | 0.7852 | 2.56 | 0.6647 | 54.69 | 10.79 | 14.68 | -53.54 | -3.70 | 9.85 | -- |
| Evotec SE | 820.80m | -94.98m | 2.35bn | 5.09k | -- | 2.05 | -- | 2.86 | -0.5371 | -0.5371 | 4.64 | 6.45 | 0.3634 | 19.15 | 5.44 | 165,751.60 | -4.21 | 2.35 | -5.08 | 2.83 | 26.78 | 25.86 | -11.57 | 6.22 | 2.09 | 0.0208 | 0.3404 | 0.00 | 21.59 | 23.29 | -181.51 | -- | 59.47 | -- |
| MorphoSys AG | 238.28m | -189.73m | 2.55bn | 524.00 | -- | 51.90 | -- | 10.72 | -5.58 | -5.58 | 6.94 | 1.30 | 0.1077 | 1.18 | 3.86 | 454,729.60 | -8.58 | -10.25 | -9.78 | -11.61 | 78.62 | 85.92 | -79.63 | -78.53 | 2.84 | -- | 0.8403 | -- | -14.37 | 25.53 | -25.60 | -- | 3.11 | -- |
